YARDLEY, Pa., July 16, 2019 /PRNewswire/ -- Astarte Medical, the only precision medicine company using software and predictive analytics to improve preterm infant outcomes, today announced t

VISTA, Calif., July 16, 2019 /PRNewswire/ -- In keeping with their growing reputation as a leading producer of top-quality nutritional products and ingredients, The GHT Companies now produce organic vitamins and supplements, as well as source individual ingredients.Becoming an

SAN FRANCISCO, July 16, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will release its second quarter 2019 financial results on August 1, 2019, after the market close. The Company will host a conference call at

SAN RAFAEL, Calif., July 16, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, August 1, at 4:30 p.m. ET to discuss second quarter 2019 financia

SAN DIEGO and PENNINGTON, N.J, July 16, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today published a Letter to Shareholders from President and Chief Executive Officer, Daniel J. O'Connor.  A copy of

SALT LAKE CITY, July 16, 2019 /PRNewswire/ -- Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report financial results for the third quarter of fiscal year 2019 following the close of regular trading on Tuesday, August 6, 2019. The earnings news release will be followed by a conference call available to all in

FREDERICK, Md., July 16, 2019 /PRNewswire/ -- NetNoggin® released detailed results from a netnographic-qualitative research study, which investigated the utilization of technology in Alzheimer's disease (including mild cognitive impairment [MCI]), presented at the Alzheimer's Association International Conference® (AAIC) 2019 held in

CHICAGO, July 16, 2019 /PRNewswire/ -- Novian Health Inc. announced that it has obtained the CE Mark approval for its Novilase® Breast Therapy, a minimally invasive procedure that uses laser induced heat for focal destruction of breast tumors up to 2 centimeters (cm) in size. The CE Mark approval allows Novian Health to commercialize its technology in the Europe

BOCA RATON, Fla., July 16, 2019 /PRNewswire/ -- MDVIP, the national leader in affordable personalized healthcare, today announced that two family physicians in Georgia –

ORLANDO, Fla., July 16, 2019 /PRNewswire/ -- According to the Institute of Medicine, 30% of healthcare dollars are wasted, and since most Americans receive healthcare benefits from their employer, the opportunity for American businesses to solve one of our biggest challenges is immense.